Workflow
密迪斯肌(08307) - 2020 - 中期财报
MEDICSKINMEDICSKIN(HK:08307)2019-11-14 09:00

Financial Performance - For the six months ended September 30, 2019, the company reported total revenue of HKD 25,858,000, an increase of 3.4% compared to HKD 24,994,000 for the same period in 2018[6] - The company incurred a loss of HKD 1,426,000 for the six months ended September 30, 2019, compared to a loss of HKD 5,259,000 for the same period in 2018, representing a 72.9% improvement[6] - Basic and diluted loss per share for the six months ended September 30, 2019, was HKD 0.13, a decrease from HKD 0.63 for the same period in 2018[8] - The total comprehensive loss for the period was HKD 683,000, compared to a total comprehensive loss of HKD 1,490,000 for the previous period[17] - The company recorded a loss of HKD 651,000 during the period, which is an improvement from a loss of HKD 3,012,000 in the same period last year[17] - The group reported total revenue of HKD 25,858,000 for the six months ended September 30, 2019, compared to HKD 24,994,000 for the same period in 2018, representing a year-over-year increase of 3.45%[43] - The group incurred a pre-tax loss of HKD 5,198,000 for the six months ended September 30, 2019, compared to HKD 2,147,000 in the same period of 2018[47] - The group recorded a loss attributable to owners of the company of approximately HKD 0.7 million, a decrease of about 76.7% compared to a loss of approximately HKD 3.0 million for the same period last year[86] Assets and Liabilities - The company's total assets as of September 30, 2019, amounted to HKD 57,394,000, compared to HKD 33,476,000 as of March 31, 2019, indicating a significant increase[11] - The company's cash and cash equivalents increased to HKD 40,257,000 as of September 30, 2019, up from HKD 15,920,000 as of March 31, 2019[11] - The company reported a decrease in total liabilities to HKD 39,253,000 as of September 30, 2019, down from HKD 32,506,000 as of March 31, 2019[13] - The company has a net asset value of HKD 9,559,000 as of September 30, 2019, compared to HKD 55,089,000 as of March 31, 2019[15] - The company's total equity as of September 30, 2019, was HKD 34,341,000, a decrease from HKD 61,088,000 as of March 31, 2018[17] Revenue Breakdown - Revenue from consultation services was HKD 873,000, a decrease of 7.03% from HKD 939,000 in the previous year[44] - Revenue from prescription and dispensing services was HKD 7,753,000, down 9.46% from HKD 8,565,000 in the prior year[44] - Revenue from treatment services increased to HKD 17,232,000, up 11.27% from HKD 15,490,000 in the previous year[44] - Revenue from treatment services accounted for over 50% of total revenue, primarily involving injections of botulinum toxin and hyaluronic acid, as well as laser and radiofrequency treatments[86] Cash Flow and Investments - For the six months ended September 30, 2019, the company reported a net cash generated from operating activities of HKD 8,447,000, a significant increase from HKD 1,081,000 in the same period of 2018[20] - The company generated net cash from investing activities of HKD 38,790,000, a recovery from a net cash outflow of HKD 2,439,000 in the prior year[20] - The company paid dividends amounting to HKD 19,429,000 during the period, compared to HKD 721,000 in the same period last year[20] - The company acquired property, plant, and equipment for approximately HKD 1,618,000 during the six months ended September 30, 2019, compared to HKD 2,668,000 for the same period in 2018, representing a decrease of about 39.25%[57] Corporate Governance and Compliance - The company has adopted the corporate governance code as per GEM Listing Rules Appendix 15 and has complied with it during the reporting period[121] - The audit committee, consisting of three independent non-executive directors, reviewed the unaudited interim financial statements for the six months ending September 30, 2019, and found them compliant with applicable accounting standards[128] - The company’s chairman and CEO roles are held by the same individual, which is a deviation from the corporate governance code, but the board believes this structure enhances business strategy implementation[122] Future Outlook and Strategy - The company plans to focus on expanding its market presence and developing new products in the upcoming quarters[6] - The company plans to continue focusing on developing new services and products to expand market share and explore new business opportunities amid economic challenges[89] - The company is planning to expand its market presence in Southeast Asia, targeting a 25% increase in market share within the next year[130] - A strategic acquisition of a smaller tech firm is in progress, expected to enhance the company's product offerings and increase overall competitiveness in the market[130] - The company has implemented new marketing strategies that have resulted in a 30% increase in customer engagement metrics[130] - The board has approved a budget increase of 15% for marketing efforts to support the upcoming product launches and market expansion initiatives[130] - The company is focusing on sustainability initiatives, with a goal to reduce operational costs by 10% through energy-efficient technologies by the end of the fiscal year[130] Shareholder Information - The board declared a special dividend of HKD 0.04 per share, totaling HKD 19,429,000, which was distributed to shareholders on July 26, 2019[51] - The company did not recommend the payment of an interim dividend for the six months ended September 30, 2019, compared to no interim dividend in 2018[52] - As of September 30, 2019, Topline holds 274,865,400 shares, representing 56.59% of the issued share capital[117] - 富麒控股有限公司 and its controlled entities each hold 80,000,000 shares, accounting for 16.47% of the issued share capital[117] Employee Costs and Operational Efficiency - The company has reported a significant reduction in employee costs, with total employee costs of HKD 12,533,000 for the six months ended September 30, 2019, compared to HKD 12,614,000 for the same period in 2018[6] - Employee costs totaled HKD 12,533,000 for the period, slightly down from HKD 12,614,000 in the previous year[47] - Other expenses decreased by approximately 54.8% from HKD 11.5 million to HKD 5.2 million, primarily due to reduced operating lease payments and marketing expenses[96] Market and User Data - User data showed an increase in active users, with a total of 1.2 million new users added during the reporting period, marking a 20% increase compared to the previous half[130] - Approximately 78.3% of the group's customers are aged between 26 to 55 years, with about 90.1% being female[86]